Skip to main content
WOOJUNG BIO, Inc. logo

WOOJUNG BIO, Inc. — Investor Relations & Filings

Ticker · 215380 ISIN · KR7215380007 KO Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2026-03-10 Major Shareholding Noti…
Country KR South Korea
Listing KO 215380

About WOOJUNG BIO, Inc.

https://www.woojungbio.kr/eng.php

WOOJUNG BIO, Inc. is a bio-infrastructure company providing an integrated platform for research and development in the life sciences. The company's core activities are structured around three main pillars. First, it offers comprehensive pre-clinical Contract Research Organization (CRO) services, including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its advanced animal laboratory facilities. Second, it specializes in the engineering and construction of modernized research environments, offering complete solutions for building and managing smart laboratories, animal rooms, and GMP-compliant clean rooms. Third, through its 'WOOJUNG BIO Cluster' open innovation platform, it provides R&D infrastructure, incubation, and acceleration support for bio-ventures and startups, aiming to foster the new drug development ecosystem and help transform innovative ideas into therapies.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of convertible bonds and voting rights by Kolmar Holdings Co., Ltd. in Woojung Bio. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels and control.
2026-03-10 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status and changes in voting rights (specifically an agreement to delegate voting rights to Kolmar Holdings) by major shareholders of Woojung Bio. This type of filing is categorized as a Major Shareholding Notification (MRQ) as it tracks significant ownership and control changes.
2026-03-10 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) from Woojungbio, specifically detailing the 'Decision to Issue Convertible Bonds' (전환사채권 발행결정). This is a regulatory filing required by the Korea Exchange (KRX) for significant corporate financing activities. It provides detailed terms of the bond issuance, including conversion prices, interest rates, and the use of proceeds. This falls under the 'Capital/Financing Update' category as it describes a specific fundraising event through debt instruments.
2026-03-03 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 1% confidence The document is a regulatory filing from a Korean company (Woojeong Bio) announcing a significant change in financial results (revenue or profit/loss structure exceeding 15% for large corporations or 30% for others). This is a standard disclosure requirement in the Korean stock market (DART system) for preliminary earnings updates before the final audit report is finalized. Since it provides key financial highlights and performance metrics for the fiscal year, it falls under the 'Earnings Release' category.
2026-02-12 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 1% confidence The document is a formal notice from Woojung Bio regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the 11th Annual General Meeting. This is a standard regulatory disclosure in the Korean market (DART system) regarding shareholder rights and meeting preparation. Since it does not contain the full proxy materials or the meeting presentation itself, but rather serves as a regulatory notification of the record date, it falls under the general regulatory filing category.
2025-12-16 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Regulatory Filings
2025-10-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.